SARS-CoV-2 open reading frame 3a (ORF3a) protein-derived peptides presented by Human Leukocyte Antigen (HLA) class I and II (ORF3a-HLA complex)

SARS-CoV-2 ORF3a is a 275-amino acid accessory protein that functions as a viroporin, forming ion channels in host cell membranes to facilitate viral release and modulate cellular processes like autophagy and apoptosis (UniProt P0DTC3). Peptides derived from ORF3a are processed and presented on the cell surface by Human Leukocyte Antigen (HLA) Class I and Class II molecules, making them critical targets for the cellular immune response (PubMed: 32887270). CD8+ T cells recognize ORF3a-derived peptides presented by HLA Class I, leading to the direct killing of infected cells, while CD4+ T cells recognize those presented by HLA Class II to coordinate broader immune responses (PubMed: 33065005). Because ORF3a is relatively conserved compared to the Spike protein, these peptides are being investigated as components of next-generation T-cell vaccines designed to provide broader protection against emerging variants (PubMed: 34744153). Therapeutic strategies targeting these complexes include peptide-based vaccines and TCR-engineered T-cell therapies aimed at clearing persistent infections. Monitoring the T-cell response to these specific epitopes serves as a biomarker for natural immunity or vaccine efficacy.

Other names

ORF3a T-cell epitopesSARS-CoV-2 ORF3a antigenSARS-CoV-2 viroporin 3a peptidesORF3a-HLA complex

Induction of peptide-specific T-cell activation and expansion; T-cell receptor (TCR) mediated recognition of peptide-HLA complexes on infected cells leading to cytotoxic activity and cytokine production.